A small behavioral change could make you invisible to thieves in the world’s busiest tourist destinations.
Adults with chronic spontaneous urticaria symptoms despite antihistamine use had reductions in disease activity with LP-003, a novel anti-IgE antibody, vs. placebo and omalizumab, according to phase 2 ...